Nuvalent Inc logo

Nuvalent Inc

NUVL
Healthcare|Biotechnology|USA
$123.90
+0.06 (+0.05%)
Tangible Book
$14.89

Analyst Estimates

annual
{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ 11.64, 181.96, 512.91, 921.43, 1257.67 ], "ebit_estimate": [ -486.98, -394.64, -134.8, 214.61, 523.47 ], "ebitda_estimate": [ -481.29, -392.16, -41.28, 2.13, 572.23 ], "net_income_estimate": [ -449.26, -371.62, -154.3, 233.27, 520.66 ], "per_share_eps_estimate": [ -5.73, -4.44, -1.11, 2.84, 5.34 ], "eps_nri_estimate": [ -5.68, -4.55, -1.6, 2.97, 5.06 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ 14.96, 15.76, 35.85, null, null ], "pretax_income_estimate": [ -454.06, -370.86, -125.3, 258.85, 571.86 ], "operating_cash_flow_per_share_estimate": [ -3.38, -1.86, 6.19, null, null ], "roa_estimate": [ -35.8, -33.3, null, null, null ], "roe_estimate": [ -36.02, -27.06, 20.86, null, null ], "gross_margin_estimate": [ 70.5, 74.83, 73.2, 65.33, 65.33 ], "operating_cash_flow_estimate": [ -265.91, -146.33, 486.97, null, null ], "pettm_estimate": [ 0, 0, 0, 43.58, 23.19 ], "long_term_growth_rate_mean": 33.77, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": 40.82, "future_eps_nri_estimate_growth": 33.77, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": 30.08, "future_ebitda_estimate_growth": 50.95, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": 27.62, "future_pretax_income_estimate_growth": 32.06, "future_book_value_per_share_estimate_growth": 28.16, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }
quarterly
{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712" ], "revenue_estimate": [ null, 1.91, 9.65, 56.27, 34.05, 48.14, 62.5 ], "ebit_estimate": [ -120.35, -122.25, -118.79, -53.69, -106.03, -98.33, -94.02 ], "ebitda_estimate": [ -119.17, -123.25, -121.83, -99.65, -105.91, -93.71, -90.54 ], "net_income_estimate": [ -112.5, -114.91, -110.95, -34.13, -96.54, -89.17, -85.18 ], "per_share_eps_estimate": [ -1.42, -1.45, -1.41, -0.94, -1.2, -1.04, -0.77 ], "eps_nri_estimate": [ -1.41, -1.44, -1.4, -0.97, -1.21, -1.05, -0.79 ], "dividend_estimate": [ null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null ], "pretax_income_estimate": [ -113.8, -116.7, -113.63, -34.13, -96.54, -89.17, -85.18 ], "operating_cash_flow_per_share_estimate": [ -1.19, -1.22, -1.2, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null ], "roe_estimate": [ -34.97, -36.68, -28.43, null, null, null, null ], "gross_margin_estimate": [ null, 46.5, 51, 95, 95, 95, 95 ], "operating_cash_flow_estimate": [ -93.62, -95.98, -94.4, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, null, null, null ], "long_term_growth_rate_mean": 33.77, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": 40.82, "future_eps_nri_estimate_growth": 33.77, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": 30.08, "future_ebitda_estimate_growth": 50.95, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": 27.62, "future_pretax_income_estimate_growth": 32.06, "future_book_value_per_share_estimate_growth": 28.16, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }

News

2026-07-09 08:56:56
2026-06-24 20:00:04
2026-06-24 12:32:02
2026-06-22 22:00:04